KLOW 80mg
$69.99
KLOW | Regenerative Peptide Blend | Research Compound BPC-157 10mg | TB-500 10mg | KPV 10mg | GHK-Cu 50mg
What is KLOW?
KLOW is a precision-formulated research peptide blend combining four of the most extensively studied regenerative and anti-inflammatory peptides in modern preclinical research — BPC-157, TB-500, KPV, and GHK-Cu. Each component has been individually validated across a broad range of in vitro and in vivo research models, and together they represent a comprehensive multi-pathway approach to studying tissue repair, inflammation modulation, cellular regeneration, and wound healing biology.
The four peptides within the KLOW blend were selected for their complementary and potentially synergistic mechanisms of action. BPC-157 operates primarily through nitric oxide pathway modulation and angiogenesis promotion. TB-500 functions through actin regulation and cell migration facilitation. KPV exerts its effects through melanocortin receptor signaling and cytokine suppression. GHK-Cu acts via copper-dependent cellular signaling and gene expression modulation. The convergence of these four distinct yet complementary pathways makes KLOW a uniquely powerful research tool for investigators studying complex multi-system regenerative biology, inflammatory disease models, and tissue engineering applications.
Overview
KLOW is a multi-peptide research blend formulated to investigate the combined and potentially synergistic effects of four well-characterized regenerative peptides across tissue repair, anti-inflammatory, angiogenic, and cellular remodeling pathways. Its broad mechanistic coverage across multiple biological systems makes it a valuable tool for researchers studying complex wound healing, inflammatory disease, and regenerative medicine models.
Product Details
Product Name: KLOW
Type: Multi-Peptide Research Blend
Components:
BPC-157 — 10mg
TB-500 (Thymosin Beta-4 Fragment) — 10mg
KPV (Lys-Pro-Val) — 10mg
GHK-Cu (Copper Peptide GHK-Cu) — 50mg
Total Blend Weight: 80mg
Appearance: Lyophilized white powder
Purity: ≥99% per individual component (HPLC verified)
Reconstitution Fluid: Bacteriostatic Water (BW) or Sterile Saline (0.9% NaCl)
Storage: Store lyophilized blend at -20°C. Upon reconstitution, store at 4°C and use within 30 days. Do not freeze reconstituted solution. Protect from light.
Component Profiles
BPC-157 (10mg) BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a naturally occurring protective protein found in human gastric juice. In the context of the KLOW blend, BPC-157 contributes its well-documented angiogenic and tissue repair properties, primarily through modulation of the nitric oxide (NO) system, promotion of neovascularization, and cytoprotective effects across gastrointestinal, musculoskeletal, and connective tissue models.
TB-500 (10mg) TB-500 is a synthetic peptide fragment of the naturally occurring protein Thymosin Beta-4 (Tβ4), corresponding to the actin-binding domain of the parent protein. TB-500 contributes to the KLOW blend through its well-characterized roles in actin regulation, endothelial and keratinocyte cell migration, and blood vessel formation — properties central to the early and intermediate phases of tissue repair and wound healing in preclinical models.
KPV (10mg) KPV (Lys-Pro-Val) is a tripeptide fragment derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone (α-MSH). Within the KLOW blend, KPV provides targeted anti-inflammatory activity through melanocortin receptor signaling and suppression of pro-inflammatory cytokines including IL-6, IL-8, and TNF-α, contributing a potent immunomodulatory dimension to the blend's overall research profile.
GHK-Cu (50mg) GHK-Cu (Copper Peptide Glycyl-L-Histidyl-L-Lysine) is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine. As the highest-dosed component in the KLOW blend, GHK-Cu contributes broad cellular remodeling and regenerative activity through copper-dependent signaling, collagen and glycosaminoglycan synthesis stimulation, antioxidant enzyme upregulation, and gene expression modulation — properties that have been studied extensively across wound healing, skin biology, and tissue repair research.
Research Applications
The KLOW blend has been formulated to investigate multi-pathway interactions across the following research areas:
Multi-Pathway Tissue Repair Research — The combination of BPC-157's angiogenic properties, TB-500's cell migration facilitation, KPV's cytokine suppression, and GHK-Cu's collagen synthesis stimulation creates a comprehensive multi-pathway research model for studying complex tissue repair mechanisms across musculoskeletal, gastrointestinal, and dermal tissue systems.
Wound Healing & Skin Biology Research — All four components have individually demonstrated wound healing properties in preclinical models. Together they are studied for their combined influence on the full wound healing cascade — from early inflammatory modulation through angiogenesis, cellular proliferation, and extracellular matrix remodeling.
Anti-Inflammatory Research — The convergence of KPV's melanocortin receptor-mediated cytokine suppression, BPC-157's NO pathway modulation, and GHK-Cu's antioxidant activity provides a multi-target approach to studying inflammatory pathway inhibition in in vitro and in vivo models.
Angiogenesis & Neovascularization Research — BPC-157 and TB-500 both contribute well-characterized pro-angiogenic properties to the blend, making KLOW a valuable tool for studying blood vessel formation, endothelial cell migration, and vascular remodeling in tissue repair models.
Extracellular Matrix & Collagen Research — GHK-Cu's potent stimulation of collagen, elastin, and glycosaminoglycan synthesis, combined with TB-500's influence on actin dynamics and cell migration, provides a rich research platform for studying extracellular matrix remodeling and connective tissue repair.
Gastrointestinal Research — BPC-157 and KPV both contribute well-documented gastrointestinal cytoprotective and anti-inflammatory properties, making KLOW relevant for preclinical research into gut barrier integrity, intestinal inflammation, and mucosal repair models.
Regenerative Medicine & Tissue Engineering — The broad and complementary regenerative profiles of all four components make KLOW a compelling research tool for tissue engineering applications, including studies involving regenerative scaffolds, bioengineered tissue constructs, and multi-peptide delivery systems.
Research Notes
KLOW is a research compound intended strictly for laboratory and in vitro/in vivo research use only. It is not approved for human consumption, therapeutic use, or veterinary application. All individual component data and findings referenced are sourced from peer-reviewed preclinical studies.
Handling & Reconstitution (For Research Use)
For research purposes, KLOW lyophilized blend is typically reconstituted using bacteriostatic water or sterile saline. Add reconstitution fluid slowly by directing it to the side of the vial and swirling gently — do not shake. Handle under sterile conditions and avoid repeated freeze-thaw cycles to maintain the integrity and potency of all peptide components. Protect reconstituted solution from direct light exposure.
Disclaimer
This product is sold for research and laboratory use only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease. Must be handled by qualified researchers in accordance with all applicable laws and regulations.